新闻中心-》媒体新闻列表页 – 智核生物

Smart Nuclide Announces the License Agreement with Hober Biotech AB For an Innovative HER2 Radioactive Imaging Agent2022年5月31日

Suzhou, China and Stockholm, Sweden, January 12, 2022 & […]

Smart Nuclide Announces FDA Clearance of IND for the First Radioactive Imaging Agent Targeting PD-L12022年5月31日

Suzhou, China, April 13, 2022 – Suzhou Smart Nucl […]

Smart Nuclide Raises 100 million yuan in a series C funding round, focusing on the development of Theranostic treatment in nuclear medicine2022年5月31日

Suzhou, China, April 13, 2022 – Suzhou Smart Nucl […]